Search - tctmd.com

Displaying 301 - 311 of 311

Sort: Relevancy | Date

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Daily News

Morbid Obesity Lowers In-Hospital Mortality in AMI Patients

Jason Kahn

February 14, 2013

News Daily News

Cardiologists Perform Bulk of Carotid Stenting Procedures

L.A. McKeown

August 09, 2011

News Daily News

Meta-analysis Supports CTA’s Predictive Value

Caitlin E. Cox

June 08, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Daily News

Calcium Scanning May Lower CAD Risk at No Extra Cost

March 23, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

News Industry News

Advertisement

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

Morbid Obesity Lowers In-Hospital Mortality in AMI Patients

Cardiologists Perform Bulk of Carotid Stenting Procedures

Meta-analysis Supports CTA’s Predictive Value

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Calcium Scanning May Lower CAD Risk at No Extra Cost

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content